Dr. Naesens en Dr. Kaes SRL
Dr. Naesens en Dr. Kaes reported total assets of €3.39m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
By total assets for 2025, Dr. Naesens en Dr. Kaes ranks among the 50 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Naesens en Dr. Kaes shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +27 % Total assets +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Naesens en Dr. Kaes's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Dr. Naesens en Dr. Kaes's financial analysis
- Solvency97.5%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Naesens en Dr. Kaes
Dr. Naesens en Dr. Kaes's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.241.163
- VAT number
- BE0846241163
- Peppol
- Registered · 0208:0846241163 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 May 2012
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Dr. Naesens en Dr. Kaes (SRL) has been based in Hasselt since 2012, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 697,085 € and equity of €3.30m; its revenue is not published. Its solvency stands at 97.5%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Naesens en Dr. Kaes
Companies in the same business, of comparable size and area, outside its group.
- Keminal Manufacture of basic pharmaceutical products Ghent · balance sheet €2.00m
- Reprobiol Manufacture of basic pharmaceutical products Ouffet · balance sheet €1.93m
- Labo Phytophar Manufacture of condiments and seasonings Oostkamp · balance sheet €10.9m
- Bioseutica Belgium Manufacture of basic pharmaceutical products Bastogne · balance sheet 836,552 €
- DeuterOncology Manufacture of basic pharmaceutical products Liège · balance sheet 688,028 €
- Promacon Manufacture of basic pharmaceutical products Hove · balance sheet 408,759 €
- Betaplus Pharma Manufacture of basic pharmaceutical products Woluwe-Saint-Lambert · balance sheet €24.9m
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
Frequently asked questions about Dr. Naesens en Dr. Kaes
What is the revenue of Dr. Naesens en Dr. Kaes?
Dr. Naesens en Dr. Kaes files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Naesens en Dr. Kaes?
In Belgium, the VAT number is the company number prefixed with BE: BE0846241163 for Dr. Naesens en Dr. Kaes, if the company is VAT-registered. Its company number (CBE) is 0846.241.163.
Where is the registered office of Dr. Naesens en Dr. Kaes?
According to the CBE register, the registered office of Dr. Naesens en Dr. Kaes is in 3500 Hasselt.
What is the equity of Dr. Naesens en Dr. Kaes?
At the close of the 2025 financial year, the equity of Dr. Naesens en Dr. Kaes amounts to 3,300,329 €, a solvency of 97.5% of total assets.
Who manages Dr. Naesens en Dr. Kaes?
The register lists 2 active mandates at Dr. Naesens en Dr. Kaes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Naesens en Dr. Kaes within its sector?
By total assets for 2025, Dr. Naesens en Dr. Kaes ranks among the 50 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of Dr. Naesens en Dr. Kaes
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →